DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» EudraVigilance
EudraVigilance
1 Conclusions and Recommendations from the Thirteenth Meeting of the WHO Advisory Committee on Safety of Medicinal Products (ACS
Medicinal Products and Medical Devices in Clinical Trials Conduct and Disclosure
Reporting Adverse Drug Reactions a Guide for Healthcare Professionals
Eudravigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection
European Medicines Agency Policy on Access to Eudravigilance Data for Medicinal Products for Human Use (Eudravigilance Access Policy)
Experiences with Adverse Drug Reaction Reporting by Patients an 11-Country Survey
Transparency of Authorities: Opportunities and Restrictions
Paediatric Safety Signals Identified in Vigibase: Methods and Results from Uppsala Monitoring Centre
Adverse Drug Reactions in Norway: a Systematic Review
Spontaneous Reports of Vasculitis As an Adverse Event Following
The Launch of the New Eudravigilance System Questions and Answers (Q&A) from Stakeholders
Screening for Adverse Reactions in Eudravigilance
ICSR)1 Implementation Guide
Introduction to the EU Telematics Programme MBTC-2010-03-005
100 Member Countries | the ABC of E2B
Pharmacovigilance
Investigating Overlap in Signals from EVDAS, FAERS, and Vigibase®
Pharmacovigilance, International Classification of Diseases And
Top View
Practical Aspects of Signal Detection in Pharmacovigilance